Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives $20.13 Average Target Price from Brokerages
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have earned a consensus rating of “Buy” from the twelve ratings firms that are currently covering the firm, MarketBeat reports. Eleven equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
Shares of Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) have earned a consensus rating of “Buy” from the twelve ratings firms that are currently covering the firm, MarketBeat reports. Eleven equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […]
